ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1068
https://www.valueinhealthjournal.com/article/S1098-3015(16)01136-0/fulltext
Title :
ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01136-0&doi=10.1016/j.jval.2016.03.1068
First page :
A249
Section Title :
Systemic Disorders/Conditions - Cost Studies
Open access? :
No
Section Order :
918